ES2127375T3 - Procedimiento de administracion de un farmaco oftalmico. - Google Patents

Procedimiento de administracion de un farmaco oftalmico.

Info

Publication number
ES2127375T3
ES2127375T3 ES94902511T ES94902511T ES2127375T3 ES 2127375 T3 ES2127375 T3 ES 2127375T3 ES 94902511 T ES94902511 T ES 94902511T ES 94902511 T ES94902511 T ES 94902511T ES 2127375 T3 ES2127375 T3 ES 2127375T3
Authority
ES
Spain
Prior art keywords
eye
therapeutic agent
medicinal product
ophthalmic
pharmacy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94902511T
Other languages
English (en)
Inventor
Donald Lewis Mackeen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deo Corp
Original Assignee
Deo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deo Corp filed Critical Deo Corp
Application granted granted Critical
Publication of ES2127375T3 publication Critical patent/ES2127375T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTA UN METODO PARA LA DISTRIBUCION PROLONGADA DE UN AGENTE TERAPEUTICO PARA EL OJO. EL METODO SE PROPORCIONA PARA LA ADICION DE UN MEDICAMENTO DESEADO PARA UN TRANSPORTADOR ADECUADO, PREFERIBLEMENTE NO ACUOSO. UNA CANTIDAD DEL TRANSPORTADOR QUE CONTIENE LA DOSIS TERAPEUTICA DEL MEDICAMENTO SE SITUA SOBRE EL EXTERIOR DE LA PIEL HACIA LA SUPERFICIE OCULAR CERCA DE LOS MARGENES DEL PARPADO LATERAL E INFERIOR. MOVIMIENTOS ORBICULARES DEL OJO ASOCIADOS CON EL CERRADO DE LOS PARPADOS DEL OJO, SEMEJANTE AL DE UNA TIJERA, TRANSPORTAN PEQUEÑAS PROPORCIONES DEL AGENTE TERAPEUTICO Y LO LLEVAN DENTRO DEL ESPACIO INTERPARPADEAL CORNEAL. ADEMAS SE PROPORCIONA UNA COMPOSICION OFTALMICA CON BASE DE CALCIO QUE ES PARTICULARMENTE EFECTIVA EN EL TRATAMIENTO DEL SINDROME DEL OJO SECO Y QUE SE DISTRIBUYE OPTIMAMENTE MEDIANTE EL METODO QUE SE ACABA DE DESCRIBIR.
ES94902511T 1992-12-08 1993-12-07 Procedimiento de administracion de un farmaco oftalmico. Expired - Lifetime ES2127375T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/986,932 US5366739A (en) 1992-08-06 1992-12-08 Method of ophthalmic drug delivery

Publications (1)

Publication Number Publication Date
ES2127375T3 true ES2127375T3 (es) 1999-04-16

Family

ID=25532895

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94902511T Expired - Lifetime ES2127375T3 (es) 1992-12-08 1993-12-07 Procedimiento de administracion de un farmaco oftalmico.

Country Status (7)

Country Link
US (1) US5366739A (es)
EP (2) EP0879601A3 (es)
AU (1) AU677980B2 (es)
CA (1) CA2129635C (es)
DE (1) DE69323303T2 (es)
ES (1) ES2127375T3 (es)
WO (1) WO1994013305A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
US5290572A (en) * 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
IT1265647B1 (it) * 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
MX9704775A (es) * 1994-12-21 1998-02-28 Cosmederm Technologies Formulaciones reductoras de irritacion de la piel y su uso.
FR2732598B1 (fr) 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
WO2002089767A1 (en) 2001-05-03 2002-11-14 Massachusetts Eye And Ear Infirmary Implantable drug delivery device and use thereof
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
WO2004103478A1 (en) 2003-05-20 2004-12-02 Collins James F Ophthalmic drug delivery system
EP1708780A4 (en) * 2003-11-14 2010-10-13 Medical Instill Tech Inc DISTRIBUTION DEVICE AND DISTRIBUTION METHOD
CN1921833A (zh) * 2004-02-26 2007-02-28 博士伦公司 藻酸盐粘弹性组合物、使用方法及包装
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
US20070053964A1 (en) * 2004-05-21 2007-03-08 Akiharu Isowaki Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist
US20080132475A1 (en) * 2006-12-05 2008-06-05 Charles Gerald Connor Treatment for dry eye
US9011361B2 (en) 2007-09-07 2015-04-21 Mati Therapeutics Inc. Lacrimal implant detection
BRPI0818483A2 (pt) * 2007-11-01 2015-04-14 Bausch & Lomb Método para preparar uma composição farmacêutica, composição farmacêutica, e, uso da mesma.
MX2010004366A (es) * 2007-11-05 2010-05-05 Bausch & Lomb Materiales inmiscibles en agua como vehiculos para suministro de farmacos.
US20100016264A1 (en) * 2007-12-05 2010-01-21 Connor Charles G Treatment for dry eye using testosterone and progestagen
US20100323978A1 (en) * 2009-06-22 2010-12-23 Calvin Hanna Non-aqueous oil delivery system for ophthalmic drugs
AU2011278934B2 (en) 2010-07-15 2015-02-26 Eyenovia, Inc. Drop generating device
WO2012009702A1 (en) 2010-07-15 2012-01-19 Corinthian Ophthalmic, Inc. Method and system for performing remote treatment and monitoring
MX2013000604A (es) 2010-07-15 2013-07-05 Corinthian Ophthalmic Inc Suministro oftálmico de fármaco.
US10154923B2 (en) 2010-07-15 2018-12-18 Eyenovia, Inc. Drop generating device
CN104487028A (zh) 2011-12-12 2015-04-01 艾诺维亚股份有限公司 高模量聚合物喷射器机构、喷射器装置及其使用方法
KR102643190B1 (ko) 2017-06-10 2024-03-04 아이노비아 인코포레이티드 유체를 취급하기 위한, 그리고 눈에 유체를 전달하기 위한 디바이스들
WO2021119513A1 (en) 2019-12-11 2021-06-17 Eyenovia, Inc. Systems and devices for delivering fluids to the eye and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070593A (en) * 1962-12-26 1967-06-01 Olin Mathieson Ophthalmic ointment composition and the preparation thereof
US5032392A (en) * 1986-09-04 1991-07-16 Vision Pharmaceuticals Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
WO1989001772A1 (en) * 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Ocular cyclosporin composition
CH679210A5 (es) * 1988-10-26 1992-01-15 Sandoz Ag
JP2827295B2 (ja) * 1989-07-04 1998-11-25 大正製薬株式会社 ビタミンａ類含有点眼剤
JP3256997B2 (ja) * 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤

Also Published As

Publication number Publication date
WO1994013305A1 (en) 1994-06-23
CA2129635A1 (en) 1994-06-23
AU677980B2 (en) 1997-05-15
DE69323303T2 (de) 1999-09-09
US5366739A (en) 1994-11-22
EP0630254A4 (en) 1997-01-15
EP0879601A2 (en) 1998-11-25
AU5686394A (en) 1994-07-04
EP0630254A1 (en) 1994-12-28
EP0879601A3 (en) 2000-08-30
CA2129635C (en) 1999-04-27
EP0630254B1 (en) 1999-01-27
DE69323303D1 (de) 1999-03-11

Similar Documents

Publication Publication Date Title
ES2116950T1 (es) Liberacion controlada de farmacos mioticos y midriaticos en la camara anterior.
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
BR0014928A (pt) Dispositivo e processo para distribuição de medicamento para um olho humano
ES2098226T3 (es) Soluciones oftalmicas acuosas y metodo para conservarlas.
ES2055120T3 (es) Procedimiento de estabilizacion de las soluciones de albumina humana y solucion obtenida.
BR9106330A (pt) Tiofeno sulfonamidas uteis como inibidores da anidrase carbonica
CA2129635A1 (en) Method of Ophthalmic Drug Delivery
ES2062102T3 (es) Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
ES2038691T4 (es) Procedimiento para la elaboracion de un medicamento para el tratamiento de inflamaciones en el ojo.
EP0546728A2 (en) Physiological tear compositions and methods for their preparation
ES2227684T3 (es) Albumina como ingrediente activo para el tratamiento de lesiones conjuntivas y de la cornea y del ojo seco.
JP7355539B2 (ja) 眼科組成物
JP7458159B2 (ja) 眼科組成物
ES2096161T3 (es) Medicamento para la aplicacion por via topica a los ojos para el tratamiento de la presion intraocular acrecentada.
DE60205913D1 (de) Ophthalmische zubereitung mit n-acetylcystein zur behandlung trockener augen
SE8304616D0 (sv) Retinaskyddsmedel for behandling av intraokulera blodningar, myopiska korioretinala dystrofier, medfodda retinadystrofier och retinabrennsar samt for forebyggande av skador vid laserkoagulering
ES2165855T3 (es) Agente de normalizacion de la coagulacion sanguinea que contiene tcf-ii como ingrediente activo.
AU643772B2 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
ES2073245T3 (es) Agentes para el tratamiento de la cornea.
ES2054244T3 (es) Acondicionamiento para una composicion oftalmologica de maleato de timolol.
KOO et al. Clinical Study of Traumatic Hyphema
KIM et al. Double-blind Study on the Effect of lndomethacin (MS-15) Eye-drops on Mydriasis During Cataract Extraction
Klein Contact shell applicator for use as a corneal bath
BG96092A (bg) Тиенотиопиранови сулфонамидни производни и приложението им в офталмологични препарати
GR3018349T3 (en) Use of naproxen as mydriatic agent.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 630254

Country of ref document: ES